With India’s semaglutide patent expiring on 20 March, about 50 branded generics are expected to enter the market.
Source link
Your Source for Trending Worldwide, Entertainment, Local, and Political News
With India’s semaglutide patent expiring on 20 March, about 50 branded generics are expected to enter the market.
Source link